News
Hosted on MSN10mon
Hispanic women are less likely to get PrEP treatment − new intervention could change that - MSNIn the U.S., Hispanic women have been disproportionately affected by the HIV epidemic in recent years. Yet they’ve been less likely to take advantage of PrEP, a medication that significantly ...
Samantha Finnie - Mission Prep Teen Treatment, Treatment Center, Rolling Hills Estates, CA, 90274, (424) 250-1072, Mission Prep California provides residential care for teens aged 13-17 struggling ...
The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...
With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo (lenacapavir), a new era of HIV prevention has dawned. | The FDA signed off ...
Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
Since the approval of the first PrEP treatment in 2012—also developed by Gilead—usage has remained stubbornly low. According to the Centers for Disease Control and Prevention, ...
In the U.S., Hispanic women have been disproportionately affected by the HIV epidemic in recent years. Yet they’ve been less likely to take advantage of PrEP, a medication that significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results